QureTech Bio AB

QureTech Bio AB is a drug development company formed in 2010 to commercialize world-leading research from groups based at Umeå University, Sweden, and Washington University, St Louis. We specialize in creating drugs for chlamydia and other pathogenic diseases.

Today, antibiotic resistance is a major problem in the world and we are creating a new class of anti-infective agents known as virulence blockers, which have the unique ability to prevent the disease-causing properties of certain pathogenic bacteria without disrupting the normal bacterial flora. Thereby, we reduce the risk of resistance development.


Contact: Fritiof Pontén

Contact details
BOX 7995, SE-90736 Umeå, Sweden
Phone: +4670 - 819 93 79